Evidence map›Paper›PMID 27762061›Full record

ArticleInfluenza and other respiratory viruses2017

Sero-epidemiologic study of influenza A(H7N9) infection among exposed populations, China 2013-2014.

Nijuan Xiang, Tian Bai, Kai Kang, Hui Yuan, Suizan Zhou, Ruiqi Ren, Xiuying Li, Jiabing Wu, Liquan Deng, Ge Zeng and 15 more

Open access · goldAbstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Biological Sex and Pregnancy Affect Influenza Pathogenesis and Vaccination.Current topics in microbiology and immunology · 2023
    Article
  5. Article
  6. Novel Avian Influenza A Virus Infections of Humans.Infectious disease clinics of North America · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 3 countries.

Nijuan XiangChinese Center for Disease Control and Prevention, Beijing, China.
Tian BaiNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China.
Kai KangHenan Provincial Center for Disease Control and Prevention, Zhengzhou, Henan Province, China.
Hui YuanJiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi Province, China.
Suizan ZhouUnited States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Ruiqi RenChinese Center for Disease Control and Prevention, Beijing, China.
Xiuying LiXinhui District Center for Disease Control and Prevention, Jiangmen, Guangdong Province, China.
Jiabing WuAnhui Provincial Center for Disease Control and Prevention, Hefei, Anhui Province, China.
Liquan DengJilin Provincial Center for Disease Control and Prevention, Changchun, Jilin Province, China.
Ge ZengHunan Provincial Center for Disease Control and Prevention, Changsha, Hunan Province, China.
Xianjun WangShandong Provincial Center for Disease Control and Prevention, Jinan, Shandong Province, China.
Shenghua MaoShanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Jian ShiHebei Provincial Center for Disease Control and Prevention, Shijiazhuang, Hebei Province, China.
Rongbao GaoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China.
Tao ChenNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China.
Sumei ZouNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China.
Dan LiChinese Center for Disease Control and Prevention, Beijing, China.
Fiona HaversUnited States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Marc-Alain WiddowsonUnited States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Carolyn M GreeneUnited States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Yanping ZhangChinese Center for Disease Control and Prevention, Beijing, China.
Daxin NiChinese Center for Disease Control and Prevention, Beijing, China.
Xiaoqing LiuJiangxi Provincial Center for Disease Control and Prevention, Nanchang, Jiangxi Province, China.
Qun LiChinese Center for Disease Control and Prevention, Beijing, China.
Yuelong ShuNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China.
Chinese Center For Disease Control and Prevention · CNNational Institute for Viral Disease Control and Prevention · CNCenters for Disease Control and Prevention · USNanchang Center for Disease Control and Prevention · CNAnhui Provincial Center for Disease Control and Prevention · CNCenters for Disease Control and Prevention · UGHealth Commission of Jilin Province · CNHebei Provincial Center for Disease Control and Prevention · CNHenan Provincial Center for Disease Control and Prevention · CNHunan Provincial Center for Disease Control and Prevention · CNNational Health and Family Planning Commission · CNShandong Center for Disease Control and Prevention · CNShanghai Municipal Center For Disease Control Prevention · CNThe Centers · USXinhui People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe first human infections of novel avian influenza A(H7N9) virus were identified in China in March 2013. Sentinel surveillance systems and contact tracing may not identify mild and asymptomatic human infections of influenza A(H7N9) virus.

objectivesWe assessed the seroprevalence of antibodies to influenza A(H7N9) virus in three populations during the early stages of the epidemic. PATIENTS/

methodsFrom March 2013 to May 2014, we collected sera from the general population, poultry workers, and contacts of confirmed infections in nine Chinese provinces reporting human A(H7N9) infections and, for contacts, second sera 2-3 weeks later. We screened for A(H7N9) antibodies by advanced hemagglutination inhibition (HI) assay and tested sera with HI titers ≥20 by modified microneutralization (MN) assay. MN titers ≥20 or fourfold increases in paired sera were considered seropositive.

resultsAmong general population sera (n=1480), none were seropositive. Among poultry worker sera (n=1866), 28 had HI titers ≥20; two (0.11%, 95% CI: 0.02-0.44) were positive by MN. Among 61 healthcare and 117 non-healthcare contacts' sera, five had HI titers ≥20, and all were negative by MN. There was no seroconversion among 131 paired sera.

conclusionsThere was no evidence of widespread transmission of influenza A(H7N9) virus during March 2013 to May 2014, although A(H7N9) may have caused rare, previously unrecognized infections among poultry workers. Although the findings suggest that there were few undetected cases of influenza A(H7N9) early in the epidemic, it is important to continue monitoring transmission as virus and epidemic evolve.

Indexed as

Seroepidemiologic StudiesAdultAnimalsAntibodies, ViralChinaFemaleHumansInfluenza A Virus, H7N9 SubtypeInfluenza, HumanInfluenza in BirdsMaleOrthomyxoviridae InfectionsPoultryYoung AdultAntibodies, Viralavian influenzaclose contactgeneral populationH7N9 viruspoultry workersserology

Identifiers

PMID27762061
PMCPMC5304573
OpenAlexW2535770254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.